Iatrogenic Kaposi sarcoma of the small bowel in Crohn's disease following short-term use of immunomodulators: a case report and review of the literature

Chia Nan University of Pharmacy & Science Institutional Repository > 智慧生活學院 > 期刊論文 > Item 310902800/34628

jsp.display-item.identifier=請使用永久網址來引用或連結此文件: https://ir.cnu.edu.tw/handle/310902800/34628

標題:	Iatrogenic Kaposi sarcoma of the small bowel in Crohn's disease following short-term use of immunomodulators: a case report and review of the literature
作者:	Wu, Pei-Jui Sun, Chi-Shu Kuo, Hsing-Tao Sheu, Ming-Jen Lin, Cheng-Yi Wang, Su-Hung Yang, Chun-Chi Chen, Chi-Hsing Chuang, Shih-Sung Feng, I-Che
貢獻者:	Chi Mei Hospital Chia Nan University of Pharmacy & Science
關鍵字:	ulcerative-colitis diagnosis patient
日期:	2022
上傳時間:	2023-12-11 14:01:27 (UTC+8)
出版者:	BMC
摘要:	Background Kaposi sarcoma is a vascular tumor highly related to human herpesvirus-8 and Kaposi sarcoma-associated herpesvirus. Kaposi sarcoma usually manifests as skin or mucosal lesions; involvement in visceral organs such as the gastrointestinal tract is rare. Kaposi sarcoma can occur in immunocompromised patients receiving immunosuppressive therapy, in which case it is known as iatrogenic Kaposi sarcoma or drug-induced Kaposi sarcoma. Intestinal Kaposi sarcoma in patients with inflammatory bowel disease is extremely rare. Case presentation A 46-year-old East Asian male with recently diagnosed Crohn's disease was administered azathioprine and prednisolone; however, the patient complained of persistent abdominal pain and diarrhea following treatment. Endoscopy revealed small bowel Kaposi sarcoma. The patient was treated with systemic chemotherapy successfully without relapse. Conclusions This is the fifth case of Kaposi sarcoma developed over the small intestine in a patient with Crohn's disease following administration of immunomodulators. Additionally, this case indicated that even short-term immunomodulator use can induce Kaposi sarcoma in patients with inflammatory bowel disease. Thus, in patients with inflammatory bowel disease, if symptoms are aggravated or do not abate after immunomodulators prescription, and before intending to upgrade immunomodulators, endoscopy should be considered. Finally, chemotherapy can also be considered if both medication withdrawal and surgical intervention are not feasible.
關聯:	JOURNAL OF MEDICAL CASE REPORTS, v.16, Article number: 424
显示于类别:	[智慧生活學院] 期刊論文

文件中的档案:

档案	描述	大小	格式	浏览次数
index.html		0Kb	HTML	290	检视/开启
s13256-022-03637-8.pdf		1439Kb	Adobe PDF	76	检视/开启

在CNU IR中所有的数据项都受到原著作权保护.

TAIR相关文章

数据加载中.....